Please login to the form below

Not currently logged in
Email:
Password:

Hydroxychloroquine

This page shows the latest Hydroxychloroquine news and features for those working in and with pharma, biotech and healthcare.

WHO trial casts doubt on remdesivir's efficacy

WHO trial casts doubt on remdesivir's efficacy

The interim results, published on the pre-print server medRxiv, showed that remdesivir, along with hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have ‘little or no effect’ on 28-day

Latest news

  • Pearls of wisdom Pearls of wisdom

    Hydroxychloroquine does not work. Ingestion of disinfectants, hand sanitiser and light into the body do not work either.

  • Speed kills Speed kills

    On 22 May, The Lancet published a research paper about hydroxychloroquine, the antimalarial drug, as a potential treatment for COVID-19. ... claimed that the use of hydroxychloroquine carried a greater risk of heart arrhythmia and death.

  • WHO takes stock of global COVID-19 R&D progress WHO takes stock of global COVID-19 R&D progress

    The WHO also took the decision to discontinue the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms following a review of evidence obtained at the interim analysis. ... These results showed that neither hydroxychloroquine nor 

  • FDA grants emergency authorisation to chloroquine for COVID-19 FDA grants emergency authorisation to chloroquine for COVID-19

    This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy. ... Although the drug was effective on its own, when added to the antibiotic azithromycin,

  • Novartis donates malaria drug for COVID-19 clinical trials Novartis donates malaria drug for COVID-19 clinical trials

    The drug, hydroxychloroquine, as well as a related drug, chloroquine, are currently being evaluated for use against COVID-19 in clinical trials around the world. ... Hydroxychloroquine is a derivative of chloroquine, and is less toxic form of the latter

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...